Hercules Capital Inc HTGC

NYS: HTGC | ISIN: US4270965084 17/09/2025

19,22 USD (+0,52%)

(+0,52%) 17/09/2025

Grafiek Hercules Capital Inc

Grafiek Hercules Capital Inc

1 dag1d 0,52%
1 week1w -1,59%
1 maand1m 0,58%
3 maanden3m 6,66%
6 maanden6m 1,48%
1 jaar1j -1,23%
5 jaar5j 67,13%

Hercules Capital Inc in het nieuws

Toon enkel gratis nieuws

8 augustus 2025 · Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile · Persbericht

17 juli 2024 · Pindrop Secures $100 Million Financing To Accelerate Fraud And Deepfake Detection Technologies · Persbericht

14 mei 2024 · Harness Raises $150 Million in New Financing · Persbericht

30 april 2024 · SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab · Persbericht

22 december 2023 · enGene Announces Expanded $50 Million Debt Facility with Hercules Capital · Persbericht

24 juli 2023 · Heron Therapeutics Announces $30 Million Private Placement Financing · Persbericht

15 mei 2023 · Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital · Persbericht

14 maart 2023 · EPAM Welcomes DeAnne Aguirre to its Board of Directors · Persbericht

14 maart 2023 · Gibraltar Business Capital Launches Gibraltar Equipment Finance · Persbericht

2 februari 2023 · Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD® · Persbericht

Profiel Hercules Capital Inc

Beleggingsbeheerders

Effecten- en grondstoffenbeurzen

Financiën en verzekeringen

Website: www.htgc.com

Hoofdzetel: Palo Alto, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe